Sort
15,273 grants matching “antimicrobial resistance”
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$784,510Alice S Prince · Columbia University Health Sciences · R35 · FY2018 · HL
Molecular Clonality of Uropathogenic E. Coli
$784,497Evgeni Veniaminovic Sokurenko · University Of Washington · R01 · FY2020 · AI
Molecular mapping of microbial communities at the host-pathogen interface by multi-modal 3-dimensional imaging mass spectrometry
$784,475Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2024 · AI
Mechanisms of multi-species bacterial interactions
$784,374Anupama Khare · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$784,138Alice S Prince · Columbia University Health Sciences · R35 · FY2019 · HL
Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
$784,115Sergei Vakulenko · University Of Notre Dame · R01 · FY2021 · AI
Role of Th17 in Severe and Recurrent C. difficile Infection
$784,076William A Petri · University Of Virginia · R01 · FY2022 · AI
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$783,685Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2024 · AI
Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of Antibiotics
$783,463Michael Zdenek David · University Of Pennsylvania · R01 · FY2019 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$783,413John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Role of Th17 in Severe and Recurrent C. difficile Infection
$783,404William A Petri · University Of Virginia · R01 · FY2023 · AI
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$783,334Alice S Prince · Columbia University Health Sciences · R35 · FY2023 · HL
Project 2: Essential metabolic objectives of M. tuberculosis aerobiology
$783,207Kyu Y Rhee · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
Optimization of novel pyranopyridine efflux pump inhibitors
$783,116Timothy J Opperman · Microbiotix, Inc · R44 · FY2016 · AI
Host factors in shigellosis
$783,065Herve F Agaisse · University Of Virginia · R01 · FY2024 · AI
VENOUS: A translational study of enterococcal bacteremia
$783,059Cesar Augusto Arias · Methodist Hospital Research Institute · R01 · FY2022 · AI
VENOUS: A translational study of enterococcal bacteremia
$783,049Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · AI
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
$782,815Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
$782,815Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments
$782,608Wim Dejonghe · Ascribe Bioscience Inc. · R44 · FY2024 · AI
Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling
$782,530George Louis Drusano · Ordway Research Institute, Inc. · R01 · FY2009 · AI
Preclinical modeling to study Tuberculous Meningitis
$782,304Sanjay Jain · Johns Hopkins University · R01 · FY2024 · AI
The role of enteric pathogens and antimicrobial resistance in driving clinical and nutritional deterioration, and azithromycin's potential effect, among children discharged from hospital in Kenya
$782,247Patricia Pavlinac · University Of Washington · R01 · FY2020 · AI
Microbial Community Disruption Following Topical Antimicrobial Application in Staphylococcus aureus-Affected Households
$781,932Stephanie Ann Fritz · Washington University · R01 · FY2022 · AI
A Culture-Free Platform for Rapid Pathogen Identification
$781,607Alon Singer · Helixbind, Inc. · R44 · FY2015 · AI